Agilus Diagnostics (formerly SRL Diagnostics)

2 apps published by Agilus Diagnostics (formerly SRL Diagnostics), tracked daily on Peekly with estimated monthly revenue and downloads.

As of August 24, 2026, Peekly estimates the qualifying Agilus Diagnostics (formerly SRL Diagnostics) portfolio generates $2k per month in store revenue across 1 category.

Publisher portfolio snapshot

Apps tracked

2

Estimated store revenue

$2k/mo

Estimated downloads

80K/mo

Store coverage

0 iOS · 2 Android

Agilus Diagnostics (formerly SRL Diagnostics) apps ranked by estimated revenue

  1. 1

    Agilus Diagnostics: Blood Test

    Google Play

    < $5k
  2. 2

    DDRC Agilus Diagnostics Lab

    Google Play

    < $5k

How Peekly estimates this portfolio

Peekly ranks qualifying store listings using public App Store and Google Play signals, download data, monetization information and daily observations. Publisher totals combine the listings shown in our dataset and remain estimates rather than official financial disclosures. Read the full methodology.

Frequently asked questions

How many apps has Agilus Diagnostics (formerly SRL Diagnostics) published?

Peekly tracks 2 public app listings published by Agilus Diagnostics (formerly SRL Diagnostics) on Google Play as of August 24, 2026.

How much revenue does Agilus Diagnostics (formerly SRL Diagnostics) make from its apps?

Peekly estimates $2k in combined monthly store revenue across the qualifying Agilus Diagnostics (formerly SRL Diagnostics) listings in this dataset. This is an estimate, not an official or audited company figure.

What is Agilus Diagnostics (formerly SRL Diagnostics)'s highest-grossing app?

Agilus Diagnostics: Blood Test ranks first in Peekly's Agilus Diagnostics (formerly SRL Diagnostics) portfolio by estimated monthly store revenue at < $5k.

What revenue is included in this publisher estimate?

Peekly estimates consumer spending through the App Store and Google Play. Advertising revenue, web checkout revenue and audited company revenue are not included.